Venture Capital in USA – Chrysalis Ventures

Chrysalis invests primarily in early-stage and expansion-stage companies in healthcare services and technology, media and communications, and business services. They will invest in other opportunities (e.g., roll-ups) but do not invest in life sciences. In general, they also do not invest in businesses which rely primarily upon patent protection or breakthrough technology as their source of competitive advantage. Chrysalis has a preference for overlooked, less crowded niches. Based in Louisville, Kentucky, Chrysalis has more than $250 million under management and has made investments in over 50 companies. They typically invest at least $2 million in the first institutional private equity financing (the “A round”) in the form of a preferred security. They will invest in later rounds of promising companies, up to a total of approximately $15 million in a single portfolio company. © Chrysalis Ventures